CA2456970A1 - Formulation de medicaments pour administration parenterale - Google Patents
Formulation de medicaments pour administration parenterale Download PDFInfo
- Publication number
- CA2456970A1 CA2456970A1 CA002456970A CA2456970A CA2456970A1 CA 2456970 A1 CA2456970 A1 CA 2456970A1 CA 002456970 A CA002456970 A CA 002456970A CA 2456970 A CA2456970 A CA 2456970A CA 2456970 A1 CA2456970 A1 CA 2456970A1
- Authority
- CA
- Canada
- Prior art keywords
- toremifene
- desmethyltamoxifen
- tamoxifen
- complex
- parenteral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013583 drug formulation Substances 0.000 title abstract 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 abstract 4
- 229960005026 toremifene Drugs 0.000 abstract 4
- XFCLJVABOIYOMF-QPLCGJKRSA-N toremifene Chemical compound C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 XFCLJVABOIYOMF-QPLCGJKRSA-N 0.000 abstract 4
- NYDCDZSEEAUOHN-IZHYLOQSSA-N N-Desmethyltamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCNC)=CC=1)/C1=CC=CC=C1 NYDCDZSEEAUOHN-IZHYLOQSSA-N 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 239000000839 emulsion Substances 0.000 abstract 2
- 239000002502 liposome Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 229960001603 tamoxifen Drugs 0.000 abstract 2
- -1 2-hydroxypropyl cyclodextrin Chemical compound 0.000 abstract 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 229940046836 anti-estrogen Drugs 0.000 abstract 1
- 230000001833 anti-estrogenic effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940088679 drug related substance Drugs 0.000 abstract 1
- 239000000328 estrogen antagonist Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919126209A GB9126209D0 (en) | 1991-12-10 | 1991-12-10 | Drug formulations for parenteral use |
GB9126209.7 | 1991-12-10 | ||
CA002125408A CA2125408C (fr) | 1991-12-10 | 1992-12-10 | Formulation de medicaments pour administration parenterale |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002125408A Division CA2125408C (fr) | 1991-12-10 | 1992-12-10 | Formulation de medicaments pour administration parenterale |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2456970A1 true CA2456970A1 (fr) | 1993-06-23 |
CA2456970C CA2456970C (fr) | 2007-01-23 |
Family
ID=32471039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002456970A Expired - Lifetime CA2456970C (fr) | 1991-12-10 | 1992-12-10 | Formulation de medicaments pour administration parenterale |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2456970C (fr) |
-
1992
- 1992-12-10 CA CA002456970A patent/CA2456970C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2456970C (fr) | 2007-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2125408A1 (fr) | Formulation de medicaments pour administration parenterale | |
CA2033725A1 (fr) | Compositions pharmaceutiques et cosmetiques | |
KR910011896A (ko) | 신규한 글리코펩티드 유도체 | |
EP0221041A3 (fr) | Dérivés de benzimidazole, leur préparation et leur application comme médicaments | |
CA2183972A1 (fr) | Derives de l'oxazolidinone et compositions pharmaceutiques contenant ces derniers | |
CA2112014A1 (fr) | Composition antiallergique pour usage ophtalmique ou nasal | |
CA2201477A1 (fr) | Nouveaux derives pyrimidone a activite antifongique | |
CA2121345A1 (fr) | Compositions de sels d'antibiotiques oligosaccharidiques lipophiles | |
CA2203033A1 (fr) | Composes et compositions pour l'administration d'agents actifs | |
EP0158481A3 (fr) | Compositions pour soins capillaires | |
IL102814A0 (en) | Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them | |
CA2173147A1 (fr) | Agent anti-obesite | |
EP0327709A3 (fr) | Complexe de platine, agent antinéoplastique le contenant, intermédiaire, méthode de préparation et utilisation | |
KR900014406A (ko) | 세펨 화합물 및 이의 제조방법 | |
CA2141964A1 (fr) | Agents pharmaceutiques contenant des acides et des sels diphosphoniques | |
GR3021231T3 (en) | Process for preparing stable hydrophilic or ambiphic cream preparations containing vesicular composnents and their use | |
GB1445995A (en) | Pharmaceutical preparations comprising n-4-2-5-chloro-2-metho xybenzamidoethyl-phenylsulphonyl-n-cyclohexylurea and salts thereof | |
CA2175470A1 (fr) | Nouvelle composition pharmaceutique destinee a la preparation d'une poudre stable contenant, a titre d'ingredient actif, une association d'acide acetylsalicylique et de metoclopramide | |
CA2456970A1 (fr) | Formulation de medicaments pour administration parenterale | |
ZA91115B (en) | Topical compositions | |
JPS57146723A (en) | Pharmaceutical preparation having improved absorption | |
CA2113080A1 (fr) | Composition topique contenant du penciclovir | |
DE59205998D1 (de) | Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung | |
AU4910590A (en) | Pyrimidinetrione derivatives, processes for their preparation, agents containing them and their use as agents for combating pests | |
JPS6056683B2 (ja) | 安定化されたカルプロニウムクロライド配合剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20121210 |